Evidence map›Paper›PMID 39689364›Full record

ArticleThe American journal of tropical medicine and hygiene2025

Genetic Characterization of Plasmodium falciparum Histidine-Rich Protein 2 Deletions and Their Impact on Malaria Interventions in Odisha, India.

Stuti Mohanty, Abbey M Jones, Swagatika Dash, Satya Ranjan Chhatria, Timir Kanta Padhan, Sanjib Mohanty, Jane M Carlton, Danielle C Ompad, Anne Kessler, Praveen Kishore Sahu

Abstract readControlled Clinical Trial
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stuti MohantyDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.
Abbey M JonesDepartment of Epidemiology, School of Global Public Health, New York University, New York, New York.
Swagatika DashDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.
Satya Ranjan ChhatriaDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.
Timir Kanta PadhanDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.
Sanjib MohantyDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.
Jane M CarltonCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, New York.
Danielle C OmpadDepartment of Epidemiology, School of Global Public Health, New York University, New York, New York.
Anne KesslerCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, New York.
Praveen Kishore SahuDepartment of Molecular Biology and Infectious Diseases, Community Welfare Society Hospital, Rourkela, Odisha, India.

Funding

Using Next-Generation Genomics to Study Antimalarial Drug Resistance in IndiaU19AI089676 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARLTON, JANE M · 2010 to 2023
$22.6M
NIAID NIH HHS U19 AI089676
6 · The paper itself

Abstract

Diagnostic escape via Plasmodium falciparum (P. falciparum) histidine-rich protein 2 (pfhrp2) gene deletions is a major potential hurdle for global malaria elimination efforts. We investigated the prevalence of pfhrp2 gene deletions in 15 malaria-endemic villages in the state of Odisha, India, and modeled their impact on an ongoing in-country malaria intervention program. We found that 61.6% of subpatent P. falciparum infections (i.e., rapid diagnostic test [RDT]-negative and positive by polymerase chain reaction [PCR]) had pfhrp2 gene deletions, which were predominantly located in the exon 2 region (96.2%) and largely identified in samples from febrile individuals (82.6%). DNA sequencing and protein diversity features were characterized in a subset of samples from individuals with subpatent infections carrying intact pfhrp2 exon 2 loci. Our analyses revealed novel amino acid repeat motifs (231-293 amino acids), and these variant repeat sequences differed from those of RDT+/PCR+ samples. We also evaluated the state-sponsored mass screening and treatment intervention in the context of pfhrp2 gene deletions. We found that mass screening and treatment conducted alongside additional interventions (e.g., long-lasting insecticidal net distribution, indoor residual spraying) reduced the relative risk of infection for both P. falciparum parasites harboring a pfhrp2 deletion (adjusted relative risk ratio [aRRR] = 0.3; 95% CI = 0.1-1.0) and P. falciparum parasites with intact pfhrp2 genes (aRRR = 0.4; 95% CI = 0.2-1.1) when compared with the use of mass screening and treatment by RDT alone. Combined, our findings highlight the need for alternative diagnostic targets and tools as India moves toward its goal of malaria elimination by 2030.

Indexed as

Communicable Disease ControlMalaria, FalciparumMass ScreeningPlasmodium falciparumRapid Diagnostic TestsAdolescentAdultAgedAmino Acid MotifsAntigens, ProtozoanChildChild, PreschoolExonsFemaleGene DeletionHumansAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID39689364
PMCPMC11884295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.